{
  "pmcid": "5760167",
  "sha256": "3418a26e3502ba6d0acba4ef23c91ddbee74d118dd30b8c031c34e7c52e8a3b1",
  "timestamp_utc": "2025-11-09T16:05:35.157462+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 18.195236363636365,
    "reading_ease": 5.091618181818205,
    "word_count": 250
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "phase III randomized study"
      },
      "Participants": {
        "score": 2,
        "evidence": "high-risk operable patients with non–small cell lung cancer"
      },
      "Intervention": {
        "score": 2,
        "evidence": "comparing stereotactic body radiotherapy and sub-lobar resection (with or without brachytherapy)"
      },
      "Objective": {
        "score": 1,
        "evidence": "to better define the role of these therapies for patients with non–small cell lung cancer"
      },
      "Method_Outcome": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "recently opened for accrual"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "American College of Surgeons Oncology Group Z4099/Radiation Therapy Oncology Group 1021"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 8,
    "max_score": 25
  }
}